Journal Article Summary
The article investigates the safety of administering 500 mg of thiamine, also known as vitamin B1, via intravenous (IV) push in adult patients. Thiamine is crucial for converting carbohydrates into energy and is often used to treat deficiencies, particularly in patients with alcohol use disorder or critical illnesses. While thiamine is generally considered safe, there have been rare reports of severe allergic reactions and other complications associated with its parenteral use. Understanding the safety profile of higher doses of thiamine given as an IV push is important for optimizing treatment protocols and ensuring patient safety.
The study was conducted at Brigham and Women's Hospital in Boston, where researchers reviewed electronic health records of adult patients who received 500 mg of thiamine via IV push from July to December 2020. A total of 463 doses were administered to 69 patients, with the majority given through peripheral lines. The findings revealed no cases of anaphylaxis, which is a severe allergic reaction, and only four low-grade injection site reactions were reported, accounting for 0.86% of doses. These results suggest that administering thiamine in this manner is safe and does not pose significant risks to patients.
However, the study has limitations, including its retrospective design, which may lead to inaccuracies in documentation. Additionally, the safety protocols and practices at this single institution may not reflect those at other hospitals. Patients should discuss any concerns about thiamine administration with their healthcare providers, especially if they have a history of allergies or other medical conditions that could affect their treatment. Overall, while the study indicates that IV push thiamine is safe, individual patient circumstances should always be considered in clinical decision-making.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Aldhaeefi Mohammed, McLaughlin Kevin, Goodberlet Melanie, Szumita Paul. Evaluation of the safety of 500 mg intravenous push thiamine at a tertiary academic medical center. Science Progress 2022. DOI: 10.1177/00368504221096539. PMID: 35491726. PMCID: PMC10306149.
Featured Pill Pals Product
Loratadine 10 mg --- 300 Count Bottle --- Generic For Claritin --- Major / Rugby --- Over The Counter
Loratadine 10 mg — 300 Count Bottle — Generic For Claritin — Major / Rugby — Over The Counter is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. This is an Over The Counter Product, so no prescription is required.However, your prescriber can still write for it as a prescription, if desired.
